Skip to Content

E36 (Potassium Citrate Extended-Release 15 mEq (1620 mg))

Pill with imprint E36 is Yellow, Rectangle and has been identified as Potassium Citrate Extended-Release 15 mEq (1620 mg). It is supplied by Eywa Pharma Inc..

Potassium citrate is used in the treatment of renal tubular acidosis; nephrolithiasis and belongs to the drug class urinary pH modifiers. Risk cannot be ruled out during pregnancy. Potassium citrate 15 mEq (1620 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for E36

Potassium Citrate Extended-Release

Imprint
E36
Strength
15 mEq (1620 mg)
Color
Yellow
Shape
Rectangle
Availability
Prescription only
Drug Class
Urinary ph modifiers
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Eywa Pharma Inc.
National Drug Code (NDC)
71930-0050

Get help with Imprint Code FAQs.

Related Images for "E36"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.